| Inflammatory cell infiltration of tumors: Jekyll or Hyde JE Talmadge, M Donkor, E Scholar Cancer and Metastasis Reviews 26, 373-400, 2007 | 418 | 2007 |
| Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation I Gutcher, MK Donkor, Q Ma, AY Rudensky, RA Flavell, MO Li Immunity 34 (3), 396-408, 2011 | 314 | 2011 |
| Reversal of indoleamine 2, 3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme TA Triplett, KC Garrison, N Marshall, M Donkor, J Blazeck, C Lamb, ... Nature biotechnology 36 (8), 758-764, 2018 | 231 | 2018 |
| T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine MK Donkor, A Sarkar, PA Savage, RA Franklin, LK Johnson, ... Immunity 35 (1), 123-134, 2011 | 143 | 2011 |
| IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions CH Lee, G Romain, W Yan, M Watanabe, W Charab, B Todorova, J Lee, ... Nature immunology 18 (8), 889-898, 2017 | 135 | 2017 |
| Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells MK Donkor, E Lahue, TA Hoke, LR Shafer, U Coskun, JC Solheim, ... International immunopharmacology 9 (7-8), 937-948, 2009 | 134 | 2009 |
| Tumor-and organ-dependent infiltration by myeloid-derived suppressor cells I Younos, M Donkor, T Hoke, A Dafferner, H Samson, S Westphal, ... International immunopharmacology 11 (7), 816-826, 2011 | 79 | 2011 |
| Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice F Abe, AJ Dafferner, M Donkor, SN Westphal, EM Scholar, JC Solheim, ... Cancer immunology, immunotherapy 59, 47-62, 2010 | 66 | 2010 |
| Tgf-β1 produced by activated CD4+ T Cells Antagonizes T Cell Surveillance of Tumor Development MK Donkor, A Sarkar, MO Li Oncoimmunology 1 (2), 162-171, 2012 | 55 | 2012 |
| T cell-but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer A Sarkar, MK Donkor, MO Li Oncotarget 2 (12), 1339, 2011 | 13 | 2011 |
| Abstract LB-226: Depletion of kynurenine using an engineered therapeutic enzyme potently inhibits cancer immune checkpoints both as a monotherapy and in combination with anti-PD-1 E Stone, N Marshall, M Donkor, K Triplett, J Blazek, T Triplett, L Ehrlich, ... Cancer Research 75 (15_Supplement), LB-226-LB-226, 2015 | 9 | 2015 |
| Correction: corrigendum: IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions CH Lee, G Romain, W Yan, M Watanabe, W Charab, B Todorova, J Lee, ... Nature Immunology 18 (10), 1173-1173, 2017 | 4 | 2017 |
| IgG immune complexes inhibit naïve T cell proliferation and suppress effector function in cytotoxic T cells W Charab, MG Rosenberger, H Shivram, JM Mirazee, M Donkor, ... Frontiers in Immunology 12, 713704, 2021 | 3 | 2021 |
| 1478 Dipeptidyl peptidase 4 (DPP4) inhibition is not solely responsible for the anti-tumor effects of BXCL701, an inhibitor of multiple DPPs, in a murine model of pancreatic … A Lekan, R Maynard, ZX Malchiodi, A Zuo, SA Jablonski, V Agarwal, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC … MK Donkor, V Agarwal, S Kupchick, R Deshpande, D Newmin, V O’Neill Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 25 Potential predictive biomarkers for BXCL701 in acute myeloid leukemia (AML) V Agarwal, S Trivedi, D Bhatia, Z Jagga, M Donkor, V O’Neill Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| IgG Fc Domains that Bind C1q but not Effector Fc? Receptors Delineate the Significance of Complement-Mediated Cell Cytotoxicity and Phagocytosis in Antibody Function CH Lee, G Romain, W Yan, M Watanabe, W Charab, B Todorova, J Lee, ... Nature Immunol, 2018 | | 2018 |
| The TGF-beta Module of T Cell Regulation in Tumor Immunity MK Donkor Cornell University, 2012 | | 2012 |
| Organ-specific biodistribution and expansion of MDSCs in tumor-bearing mice IH Younos, A Dafferner, H Samson, T Hoke, S Westphal, M Donkor, ... CLINICAL & EXPERIMENTAL METASTASIS 28 (2), 167-167, 2011 | | 2011 |
| Abstract B52: Characterizing the MDSCs phenotypes, expansion, and trafficking pattern and associated tumor-induced immune dysfunction IH Younos, T Hoke, A Dafferner, H Samson, M Donkor, S Westphal, ... Clinical Cancer Research 16 (14_Supplement), B52-B52, 2010 | | 2010 |
